基本信息
浏览量:1
职业迁徙
个人简介
He sits on several foundations, NIH and Department of Defense peer review panels and sits on several Editorial boards. He has consulted for many companies including Lilly, Parke-Davis, Pfizer, Centocor, Immunex, Amgen, Novartis, Merck and Eisai Pharmaceuticals. Key research accomplishments include (1) defining importance of osteoclastic activity and targeting it in prostate cancer leading to clinical use of RANKL inhibitor (Denosumab); (2) identification of raf kinase inhibitor protein (RKIP) as a novel metastasis suppressor gene; (3) determining the importance of the Wnt pathway in bone metastasis; and (4) defining interleukin-6 as a contributor to castration resistant prostate cancer.
研究兴趣
论文共 444 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Matthew D. Wainstein, Jake McGue,Tyler Robinson,Rohit Mehra,Simpa S. Salami, Tim Frankel,Aaron Udager,Evan T. Keller, Allison M. May, Jonathan Jiang
Urologic Oncology: Seminars and Original Investigations (2024)
Allison M. May, Claire Williams, Shaye Hagler, Michael McNiff,Tyler Robinson,Simpa Salami,Aaron Udager,Evan T. Keller
Research square (2024)
Allison M. May, Matthew Wainstein, Jake McGue,Tyler Robinson,Rohit Mehra,Simpa S. Salami, Tim Frankel,Aaron Udager,Evan T. Keller
CANCER RESEARCHno. 11 (2023): A067-A067
引用0浏览0引用
0
0
The Journal of Urologyno. Supplement 4 (2023): E500-E501
引用0浏览0引用
0
0
Allison May, Claire Williams,Stephanie The,Jake Mcgue, Sean Kim, Nathan Schurman,Greg Shelley,Tyler Robinson, Simpa Salami,Rohit Mehra,Timothy Frankel,Aaron Udager,
CANCER RESEARCHno. 16 (2023): PR014-PR014
CANCER RESEARCHno. 7 (2023): 5581-5581
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn